Table 4.
Difference in SUVs between the epileptogenic and contralateral sides by postsurgical outcomes
No disabling seizures (n=25) | Residual disabling seizures (n=8) | p-value | |
---|---|---|---|
SUVmax BG | 0.1 (0.6) | 0.04 (0.5) | 0.87 |
SUVpeak BG | 0.1 (0.5) | -0.2 (0.3) | 0.15 |
SUVmax thalamus | -0.4 (0.9) | -0.2 (1.3) | 0.38 |
SUVpeak thalamus | -0.2 (0.8) | -0.7 (1.1) | 0.25 |